JAMP ATOMOXETINE
Identification of Jamp Atomoxetine
No description |
Google image searchProduct monograph
Active ingredient
atomoxetine (atomoxetine hydrochloride), 25 MG
DIN: 02506823
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 30-JAN-2023
ATC:
- N06 — PSYCHOANALEPTICS (ATC, ATC/DDD, )
- N06B — PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS (ATC, ATC/DDD)
- N06BA — Centrally acting sympathomimetics (ATC, ATC/DDD)
- N06BA09 — ATOMOXETINE (ATC/DDD)
Reference brand drug: Strattera
Pharmaceutical standard: MFR